In the brain, sEH inhibition promotes brain tissue protection, and it has been proven effective in reducing neuroinflammation, endoplasmic reticulum stress (ERS), amyloid accumulation, and p-Tau pathology, preventing memory impairment in AD mice model [17] Thus, targeting sEH could represent a therapeutic approach to AD treatment. Here, MAPT is linked to Alzheimer disease.